RS Rearrangement Frequency as a Marker of Receptor Editing in Lupus and Type 1 Diabetes

Journal of Experimental Medicine - United States
doi 10.1084/jem.20082053
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Rockefeller University Press

Related search

Exhaled Methyl Nitrate as a Noninvasive Marker of Hyperglycemia in Type 1 Diabetes

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2007English

Reduced Receptor Editing in Lupus-Prone MRL/lpr Mice

Journal of Experimental Medicine
MedicineAllergyImmunology
2007English

Cannabinoid-1 Receptor Antagonists in Type-2 Diabetes

Best Practice and Research in Clinical Endocrinology and Metabolism
EndocrinologyMetabolismDiabetes
2007English

Interleukins as a Marker of Inflammation in Diabetic Foot Syndrome and Type 2 Diabetes Mellitus

Bezmialem Science
2019English

Systematic Assessment of Immune Marker Variation in Type 1 Diabetes: A Prospective Longitudinal Study

Frontiers in Immunology
AllergyImmunology
2019English

THU0018 Angiotensinogen as a Marker of Injury in Lupus Nephritis

2017English

Adiponectin Receptor Fragmentation in Mouse Models of Type 1 and Type 2 Diabetes

2019English

Serum Visfatin as a Novel Marker of Endothelial Dysfunction in Patients With Type 2 Diabetes

International Journal of Contemporary Medical Research [IJCMR]
2018English

Frequency of CD4+CD25hiFOXP3+ Regulatory T Cells in Type 1 Diabetes Mellitus

International Journal of Advanced Research
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy